Go Ad-Free
    My Alerts
    Moneycontrol
    Moneycontrol PRO
    Loans
    Loans
    HomeNewsKwalitypharmaceuticals

    Stock analysis is used by traders to make buy and sell call. It’s an approach to make informed decisions while investing in stocks. Stock analysis can be categorised into – fundamental analysis and technical analysis. Fundamental analysis is evaluation of data from sources, including financial records, economic reports, company assets, and market share. Analysts typically study the company’s financial statements – balance sheet, income statement, cash flow statement, and footnotes. These statements are made available to the investors in the form of quarterly earnings, disclosures to stock exchanges in compliance with the Securities and Exchange Board of India (Sebi) norms. In fundamental analysis, the analysts particularly check for a company's core income, income from other sources, profitability, guidance, assets and liabilities and debt ratio among other parameters. The other method, i.e. the technical analysis focuses purely on statistical data. It works on two assumptions; one, the stock price reflects the fundamentals. Second, the study of past and present movement in prices can help determine the future price trends. Technical analysis primarily deals with price, volume, demand and supply factors. This method is effective only when supply and demand forces influence the market. However, when outside factors are involved in a price movement, technical analysis may not be successful. More

    Jump to

    • Trade Spotlight: How should you trade Larsen & Toubro, Narayana Hrudayalaya, JSW Energy, Bajaj Finance, PFC, and others on March 4?

      The market may attempt a bounce back considering the oversold conditions, but it is unlikely to sustain the same. Below are some trading ideas for the near term.

    • Trade Spotlight: How should you trade Abbott India, NALCO, ITC, Vishnu Chemicals, Power Grid, and others on Tuesday?

      The bearish sentiment is expected to continue, as the market traded well below all key moving averages (10-20-50-100 EMAs). Below are some trading ideas for the near term.

    • Hot Stocks | Bet on Cipla, UTI AMC, Abbott India for double-digit healthy return in short term. Here's why

      Cipla has given a breakout of downward slopping trend line with volume confirmation indicating positive strength of the stock.

    • Trade Spotlight | What should you do with Abbott India, ITC, Power Grid Corporation on Monday?

      Power Grid Corporation of India is in a strong uptrend across all timeframes and is approaching an all-time high breakout of Rs 241

    • Trade Spotlight | What should you do with Rain Industries, Coal India, SBI Card, Abbott India?

      Here's what Jigar S Patel of Anand Rathi Shares & Stock Brokers recommends investors should do with these stocks when the market resumes trading today.

    • Trade Spotlight: What should investors do with Abbott India, KPR Mill and Apollo Pipes?

      Here's what Shrikant Chouhan of Kotak Securities recommends investors should do with these stocks when the market resumes trading today.

    • Market rally getting broad-based for the first time since FY17: ICICI Securities

      Since FY17, the market's performance was mostly driven by a handful of stocks, as broader indices underperformed significantly.

    • Build your diversified and secured Rs 1 crore portfolio in Samvat 2077 by investing in these 13 stocks

      If you are a retail investor have Rs 1 crore to invest, here are a few recommendations for investing and dividing your portfolio exposure across these sectors.

    • As market valuations turn expensive, brokerages pick these 27 stocks

      In muted earnings expectations for Q1FY21, beats were much higher than misses and that was one of major reasons and confidence booster for equity market not only in India but globally.

    • Pharma index up 45% from March lows; CLSA says earnings momentum to continue, raises targets

      The Nifty Pharma index gained half a percent on May 7, taking gains to around 45 percent since March 23.

    • Pharma sector sits pretty amid market turmoil; 5 stocks that you can buy

      The panic created by COVID-19 has taken a heavy toll on most sectors but pharma companies seem to have withstood the carnage, with some stocks delivering healthy returns during this period.

    • Volatility to continue in Nifty, bet on these 5 stocks for 15-22% return: Ashish Chaturmohta

      VIX needs to move below 50 levels for some stability to return in the market, otherwise expect volatile moves to continue in the market.

    • Top 10 buying ideas for double-digit returns as experts say stay stock-specific

      In a rangebound trade, experts advised focusing more on stock selection and trade management. Here is the list of 10 stocks which could return 14-24 percent in next 10-12 months:

    • Midcap recovery may be on cards; 20 stock picks by Elara Capital

      Elara Capital expects a revival in midcaps riding on price and valuation comfort based on historical trends, strong flows from FPIs and DIIs and strong earnings revival

    • Buy Abbott India, target Rs 8,450: Dharmesh Shah

      We expect the stock to resume fresh up move and test levels of Rs 8450 levels in the medium term, says Dharmesh Shah of ICICI Securities.

    • Buy ABB, target Rs 1550: Dharmesh Shah

      We believe that the stock is likely to continue with its positive momentum and head towards Rs 1550 in the medium-term, says Dharmesh Shah of ICICIdirect.com.

    • Buy ABB India, target Rs 1550: Dharmesh Shah

      The weekly 14-periods RSI has been inching upward after recently recording bullish crossover, indicating an acceleration of positive momentum in the short term, says Dharmesh Shah of fICICIdirect.com Research.

    • Accumulate ABB, target Rs 1,540: Nandish Shah

      We recommend investors to accumulate ABB in the range of Rs 1,390-1,423 for the upside target of Rs 1,540, and a stop loss placed below Rs 1,360, says Nandish Shah of HDFC Securities.

    • Buy or sell: Top stock trading ideas by market experts which are good short term bets

      Rajesh Agarwal of AUM Capital recommends buying Can Fin Homes with stop loss at Rs 252 and target of Rs 274 and Lakshmi Vilas Bank with stop loss at Rs 82 and target of Rs 90.

    • Top buy & sell ideas by Rajat Bose, Prakash Gaba, Rahul Mohindar for short term

      Rahul Mohindar of viratechindia.com is of the view that one can sell Tata Consultancy Services with target of Rs 2085 and stop loss at Rs 2085 and buy Dr Reddy's Laboratories with target of Rs 2680 and stop loss at Rs 2460.

    • RBL Bank, Prabhat Dairy among top 10 stocks that could return 15-60% over 1-year

      RBL Bank is likely to see improving return profile over the next couple of years, due to improving advances & loan mix, higher CASA, lower cost ratios and improving asset quality

    • Midcaps stocks likely to outperform Nifty! 3 stocks which could give up to 17% returns in 1-6 months

      The sharp up move in the last three sessions from the support area has seen the index almost testing their embarked target of 11,600.

    • 11,500 may act as crucial resistance for Nifty; 2 largecaps, 1 midcap that could return 8-11%

      Rupak De of Bonanza Portfolio said the Nifty may find support at the lower band of the rising channel which is currently pegged around 11,450. “On the higher end, 11,600 and 11,660 are likely to act as immediate resistance.”

    • Podcast | Stock picks of the day: Small & midcaps likely to play catch up with benchmarks

      The midcap and smallcap space continued to outperform even in this week registering the second consecutive week of smart gains. We expect the broader indices to play a catch up with benchmarks.

    • Buy or sell: Top stock trading ideas by market experts which are good short term bets

      Rajesh Agarwal of AUM Capital recommends buying Adani Enterprises with stop loss at Rs 192 and target of Rs 205, Venkys with stop loss at Rs 2618 and target of Rs 2820 and Jet Airways with stop loss at Rs 319 and target of Rs 350.

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347